INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 4 analysts with an average price target of $14.84. This is a potential upside of $12.88 (657.14%) from yesterday's end of day stock price of $1.96.

Inovio Pharmaceuticals's activity chart (see below) currently has 101 price targets and 106 ratings on display. The stock rating distribution of INO is 88.89% HOLD and 11.11% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.5% with an average time for these price targets to be met of 544.57 days.

Highest price target for INO is $6, Lowest price target is $4, average price target is $14.84.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Nov-2024. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 8 are a HOLD (88.89%), 1 are a BUY (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$2.68 (115.52%)

$15

29 days ago
(18-Nov-2024)

4/6 (66.67%)

$0.88 (21.36%)

914

Hold

$6

$3.68 (158.62%)

$7

1 months 2 days ago
(15-Nov-2024)

13/18 (72.22%)

$1.75 (41.18%)

417

Buy

$4

$1.68 (72.41%)

10 months 22 days ago
(25-Jan-2024)

2/2 (100%)

$-2.79 (-41.09%)

367

Hold

$4.8

$2.48 (106.90%)

1 years 1 months 7 days ago
(10-Nov-2023)

1/1 (100%)

$0.61 (14.56%)

6

Hold

$240

2 years 1 months 8 days ago
(09-Nov-2022)

7/8 (87.5%)

$94.32 (64.74%)

713

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 544.57 days on average for the stock forecasts to be realized with a an average price target met ratio 86.5

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 9 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Thomas Shrader with highest potential upside - $129.68

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?